{"id":64100,"date":"2026-08-21T19:44:58","date_gmt":"2026-08-21T17:44:58","guid":{"rendered":"https:\/\/carlosoconnor.es\/?p=64100"},"modified":"2026-08-21T19:45:04","modified_gmt":"2026-08-21T17:45:04","slug":"soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos","status":"publish","type":"post","link":"https:\/\/carlosoconnor.es\/en\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/","title":{"rendered":"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS"},"content":{"rendered":"

La reciente revisi\u00f3n publicada en el International Journal of Molecular Sciences por G\u00f3mez-Maldonado y colaboradores analiza el papel emergente de los agonistas del receptor GLP-1 (como la liraglutida) y los agonistas duales GIP\/GLP-1 (como la tirzepatida) en la . La evidencia cl\u00ednica demuestra que estos f\u00e1rmacos reducen significativamente el \u00cdndice de Apnea-Hipopnea (IAH) y mejoran el perfil cardiometab\u00f3lico. La aprobaci\u00f3n de la tirzepatida por la FDA como tratamiento para la AOS moderada a severa en adultos con obesidad confirma que reducir el tejido graso perifar\u00edngeo y visceral alivia sustancialmente la carga mec\u00e1nica e inflamatoria sobre la v\u00eda a\u00e9rea superior, ofreciendo un soporte farmacol\u00f3gico crucial cuando la adherencia a la CPAP resulta dif\u00edcil.

Enlace de referencia: https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7108<\/a>

hashtag#ApneaDelSue\u00f1o<\/a> hashtag#MedicinaDelSue\u00f1o<\/a> hashtag#Otorrinolaringologia<\/a> hashtag#TerapiaMiofuncional<\/a> hashtag#GLP1<\/a> hashtag#Tirzepatida<\/a> hashtag#AOS<\/a> hashtag#SaludRespiratoria<\/a> hashtag#Sue\u00f1oReparador<\/a> hashtag#TratamientoIntegral<\/a><\/p>\n\n\n\n

\"images
images 2026 07 29T064447.540<\/figcaption><\/figure>","protected":false},"excerpt":{"rendered":"

La reciente revisi\u00f3n publicada en el International Journal of Molecular Sciences por G\u00f3mez-Maldonado y colaboradores analiza el papel emergente de los agonistas del receptor GLP-1 (como la liraglutida) y los…<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64100","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nSoporte farmacol\u00f3gico en casos de pacientes obesos con AOS - Carlos O'Connor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/carlosoconnor.es\/en\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS - Carlos O'Connor\" \/>\n<meta property=\"og:description\" content=\"La reciente revisi\u00f3n publicada en el International Journal of Molecular Sciences por G\u00f3mez-Maldonado y colaboradores analiza el papel emergente de los agonistas del receptor GLP-1 (como la liraglutida) y los…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/carlosoconnor.es\/en\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/\" \/>\n<meta property=\"og:site_name\" content=\"Carlos O'Connor\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-21T17:44:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-21T17:45:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/08\/images-2026-07-29T064447.540.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"619\" \/>\n\t<meta property=\"og:image:height\" content=\"348\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gestion\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"gestion\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/\"},\"author\":{\"name\":\"gestion\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#\\\/schema\\\/person\\\/c879dbc2b732eaa32429f50dfbd0a949\"},\"headline\":\"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS\",\"datePublished\":\"2026-08-21T17:44:58+00:00\",\"dateModified\":\"2026-08-21T17:45:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/\"},\"wordCount\":167,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/carlosoconnor.es\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/images-2026-07-29T064447.540.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/\",\"url\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/\",\"name\":\"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS - Carlos O'Connor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/carlosoconnor.es\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/images-2026-07-29T064447.540.jpg\",\"datePublished\":\"2026-08-21T17:44:58+00:00\",\"dateModified\":\"2026-08-21T17:45:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/carlosoconnor.es\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/images-2026-07-29T064447.540.jpg\",\"contentUrl\":\"https:\\\/\\\/carlosoconnor.es\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/images-2026-07-29T064447.540.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/carlosoconnor.es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#website\",\"url\":\"https:\\\/\\\/carlosoconnor.es\\\/\",\"name\":\"Carlos O'Connor\",\"description\":\"Dr. Carlos O'Connor Reina - Otorrinolaring\u00f3logo\",\"publisher\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/carlosoconnor.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#organization\",\"name\":\"Carlos O'Connor\",\"url\":\"https:\\\/\\\/carlosoconnor.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/carlosoconnor.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cropped-logo-wide.png\",\"contentUrl\":\"https:\\\/\\\/carlosoconnor.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cropped-logo-wide.png\",\"width\":241,\"height\":50,\"caption\":\"Carlos O'Connor\"},\"image\":{\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/carlosoconnor.es\\\/#\\\/schema\\\/person\\\/c879dbc2b732eaa32429f50dfbd0a949\",\"name\":\"gestion\",\"sameAs\":[\"https:\\\/\\\/www.ycomieronperdices.net\\\/temp\\\/oconnor2025\"],\"url\":\"https:\\\/\\\/carlosoconnor.es\\\/en\\\/author\\\/gestion\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS - Carlos O'Connor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/carlosoconnor.es\/en\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/","og_locale":"en_GB","og_type":"article","og_title":"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS - Carlos O'Connor","og_description":"La reciente revisi\u00f3n publicada en el International Journal of Molecular Sciences por G\u00f3mez-Maldonado y colaboradores analiza el papel emergente de los agonistas del receptor GLP-1 (como la liraglutida) y los…","og_url":"https:\/\/carlosoconnor.es\/en\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/","og_site_name":"Carlos O'Connor","article_published_time":"2026-08-21T17:44:58+00:00","article_modified_time":"2026-08-21T17:45:04+00:00","og_image":[{"width":619,"height":348,"url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/08\/images-2026-07-29T064447.540.jpg","type":"image\/jpeg"}],"author":"gestion","twitter_card":"summary_large_image","twitter_misc":{"Written by":"gestion","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#article","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/"},"author":{"name":"gestion","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949"},"headline":"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS","datePublished":"2026-08-21T17:44:58+00:00","dateModified":"2026-08-21T17:45:04+00:00","mainEntityOfPage":{"@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/"},"wordCount":167,"commentCount":0,"publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"image":{"@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/08\/images-2026-07-29T064447.540.jpg","articleSection":["Uncategorized"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/","url":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/","name":"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS - Carlos O'Connor","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#primaryimage"},"image":{"@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/08\/images-2026-07-29T064447.540.jpg","datePublished":"2026-08-21T17:44:58+00:00","dateModified":"2026-08-21T17:45:04+00:00","breadcrumb":{"@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#primaryimage","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/08\/images-2026-07-29T064447.540.jpg","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/08\/images-2026-07-29T064447.540.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/carlosoconnor.es\/soporte-farmacologico-en-casos-de-pacientes-obesos-con-aos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/carlosoconnor.es\/"},{"@type":"ListItem","position":2,"name":"Soporte farmacol\u00f3gico en casos de pacientes obesos con AOS"}]},{"@type":"WebSite","@id":"https:\/\/carlosoconnor.es\/#website","url":"https:\/\/carlosoconnor.es\/","name":"Carlos O'Connor","description":"Dr. Carlos O'Connor Reina - Otorrinolaring\u00f3logo","publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/carlosoconnor.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/carlosoconnor.es\/#organization","name":"Carlos O'Connor","url":"https:\/\/carlosoconnor.es\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","width":241,"height":50,"caption":"Carlos O'Connor"},"image":{"@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949","name":"gestion","sameAs":["https:\/\/www.ycomieronperdices.net\/temp\/oconnor2025"],"url":"https:\/\/carlosoconnor.es\/en\/author\/gestion\/"}]}},"_links":{"self":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/64100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/comments?post=64100"}],"version-history":[{"count":1,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/64100\/revisions"}],"predecessor-version":[{"id":64102,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/64100\/revisions\/64102"}],"wp:attachment":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/media?parent=64100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/categories?post=64100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/tags?post=64100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}